You have 9 free searches left this month | for more free features.

Non-WNT non-SHH medulloblastoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)

Active, not recruiting
  • Brain Tumor
  • +12 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 20, 2022

Brain and CNS Tumors Trial in Australia, Canada, United States (biological, drug, procedure, radiation)

Active, not recruiting
  • Brain and Central Nervous System Tumors
  • filgrastim
  • +5 more
  • Durham, North Carolina
  • +8 more
Dec 17, 2021

Medulloblastoma Trial in Memphis (procedure, drug, radiation)

Recruiting
  • Medulloblastoma
  • Surgical resection
  • +11 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Sep 16, 2022

Medulloblastoma, CNS Embryonal Tumors Trial in Canada, New Zealand, United States (Induction, Single Cycle Intensive

Recruiting
  • Medulloblastoma
  • Central Nervous System Embryonal Tumors
  • Birmingham, Alabama
  • +61 more
Feb 16, 2022

Medulloblastoma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Buffalo, New York, Cincinnati (SurVaxM for patients

Recruiting
  • Medulloblastoma
  • +7 more
  • SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
  • +2 more
  • Buffalo, New York
  • +2 more
Jul 8, 2022

Based on Molecular Typing of Medulloblastoma in Children

Not yet recruiting
  • Medulloblastoma, Childhood
  • Prospective observational study, no intervention
  • (no location specified)
Jun 4, 2022

Metastatic Esophageal Cancer, Metastatic Gastric Cancer Trial in Sutton (Atezolizumab)

Recruiting
  • Metastatic Esophageal Cancer
  • Metastatic Gastric Cancer
  • Sutton, Surrey, United Kingdom
    The Royal Marsden NHS Foundation Trust
Jul 12, 2021

Pancreatic Cancer Trial in Birmingham (Diet Only, Diet + Exercise)

Completed
  • Pancreatic Cancer
  • Diet Only
  • Diet + Exercise
  • Birmingham, Alabama
    University of Alabama at Birmingham
Nov 16, 2021

Lymphoma, Childhood Lymphoma, Solid Tumor Trial in Charlottesville (Genistein, Placebo)

Terminated
  • Lymphoma
  • +15 more
  • Charlottesville, Virginia
    University of Virginia
Feb 8, 2022

Medulloblastoma Trial in Worldwide (drug, other, radiation)

Recruiting
  • Medulloblastoma
  • Birmingham, Alabama
  • +192 more
Aug 17, 2022

Rare CNS Tumors Outcomes &Risk

Recruiting
  • High Grade Meningioma
  • +4 more
    • Bethesda, Maryland
      National Cancer Institute (NCI)
    Jul 6, 2022

    Medulloblastoma Trial in United States (Lomustine, Vincristine, Cisplatin)

    Terminated
    • Medulloblastoma
    • Phoenix, Arizona
    • +15 more
    Oct 8, 2021

    Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)

    Active, not recruiting
    • Brain and Central Nervous System Tumors
    • Induction Chemotherapy
    • +3 more
    • Palo Alto, California
    • +5 more
    Nov 29, 2022

    Medulloblastoma, CNS Tumor, Pediatric, Ependymoma Trial in Beijing

    Recruiting
    • Medulloblastoma
    • +5 more
      • Beijing, Beijing, China
        Beijing Tiantan Hosiptal
      Jan 3, 2023

      Desmoplastic/Nodular Medulloblastoma, Medulloblastoma, Medulloblastoma With Extensive Nodularity Trial in Worldwide

      Active, not recruiting
      • Desmoplastic/Nodular Medulloblastoma
      • +4 more
      • Birmingham, Alabama
      • +172 more
      Jan 4, 2022

      Klotho _ LRP-6 _ Gastric Adenocarcinoma

      Not yet recruiting
      • Gastric Adenocarcinoma
      • +2 more
      • Prognostic study
      • (no location specified)
      Jan 29, 2023

      Medulloblastoma Trial in Zürich (Sonidegib, Cisplatin, Lomustine)

      Not yet recruiting
      • Medulloblastoma
      • Zürich, Switzerland
        University Hospital zurich
      May 20, 2020

      H. Pylori Infection, Carcinogenesis Trial in Tainan (probiotic)

      Recruiting
      • H. Pylori Infection
      • Carcinogenesis
      • probiotic
      • Tainan, Taiwan
        National Cheng Kung University & Hospital
      Sep 15, 2022

      Advanced Malignant Solid Tumor, Recurrent Childhood Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

      Active, not recruiting
      • Advanced Malignant Solid Neoplasm
      • +31 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Birmingham, Alabama
      • +118 more
      Jan 27, 2023

      Medulloblastoma Trial (drug, other, radiation)

      Recruiting
      • Medulloblastoma
      • Madera, California
      • +1 more
      Jan 30, 2023

      Advanced Malignant Solid Tumor, Recurrent Ependymal Tumor, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

      Active, not recruiting
      • Advanced Malignant Solid Neoplasm
      • +35 more
      • Birmingham, Alabama
      • +108 more
      Oct 19, 2022

      Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin

      Active, not recruiting
      • Advanced Malignant Solid Neoplasm
      • +35 more
      • Birmingham, Alabama
      • +113 more
      Jun 28, 2022

      Untreated Childhood Medulloblastoma Trial in Worldwide (drug, radiation, other)

      Active, not recruiting
      • Untreated Childhood Medulloblastoma
      • Birmingham, Alabama
      • +177 more
      Feb 25, 2022

      Myocardial Infarction, Myocardial Fibrosis, Myocardial Remodeling, Ventricular Trial in Messina (P2Y12 Potent Inhibitor +

      Recruiting
      • Myocardial Infarction
      • +2 more
      • P2Y12 Potent Inhibitor + Aspirin for STEMI patients
      • Clopidogrel + Aspirin for CCS patients
      • Messina, Italy
        AOU Policlinico G. Martino
      Jan 21, 2023

      Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial in Puerto

      Recruiting
      • Malignant Solid Neoplasm
      • +26 more
      • Birmingham, Alabama
      • +121 more
      Aug 24, 2022